The topical drug delivery market is growing at high rates, mainly due to the increasing incidence of skin infections such as psoriasis, eczema, acne, and others. Moreover, the increasing incidences of burn injuries, the prevalence of diabetes and eye disease, and the extensive use of drugs to treat diabetic neuropathic pain and foot ulcers are also expected to accelerate the market's overall growth. The semi-solid formulations segment accounted for the majority of revenue share in the global market in 2021. Factors boosting the growth of this segment include the growing demand for semi-solid topical drug formulations such as ointments, creams, gels, and lotions, due to their advantages such as easy application, more effective delivery of drug molecules, and non-invasive nature.
Within the report, the market is segmented on the basis of product, route of administration, and end user. Based on product, the market is segmented as liquid formulations, semi-solid formulations, solid formulations and transdermal products. On the basis of route of administration, the market is segmented into nasal drug delivery, ophthalmic drug delivery, dermal drug delivery, rectal drug delivery, vaginal drug delivery, and pulmonary drug delivery. On the basis of end-user, the market is segmented into burn centers, hospitals and clinics, home care settings, and other end users. Geographically, the market is subsegmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.
Topical drug delivery is the application of medication to the skin's surface or within the layers of skin or mucous membrane. These drugs are generally applied to a certain part of the body; usually, the skin, to treat different ailments. After the application on the skin, the drug primarily enters through the stratum corneum and passes via the deeper epidermis and dermis with no drug accumulation in the dermal layer.
Furthermore, burn injuries are one of the most devastating of all injuries, accounting for the fourth most common kind of trauma worldwide. For instance, as per the Lancet Public Health, one of the leading journals in global health, burns and wound were one of the main reasons for disability, with over 8 million disability-adjusted life-years (DALYs). The burn wounds are mainly treated with the help of topical agents and wound dressings according to their extent and stage. Therefore, the rising occurrence of burn injuries creates demand for topical drug delivery.
The significant rise in the geriatric population and the closing of regular OPDs during the global pandemic has surged the demand for self-administration drugs within home care settings. The elderly population forms a large consumer base for topical drugs in-home care. This factor also increases the demand for inhalation, topical, and transdermal drug products designed to cater to the needs of caregivers and patients.
The topical drug delivery market has undergone several significant developments, and a few of these have been mentioned below:
Several players drive the topical drug delivery market by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnershipsSOLVAY S.A., Cipla Limited, GlaxoSmithKline PLC, Novartis International AG, Crescita Therapeutics Inc., Bayer AG, Galderma S.A., Janssen Global Services LLC (Johnson and Johnson), and Sienna Biopharmaceuticals is among the prominent players operating in the market.
Scope of the report:
In this report, the market has been segmented on the basis of: